REGULATORY News

Absentia Labs' AI Digital Liver Model First to Enter FDA Qualification Program

Absentia Labs' Digital Liver Model, an AI-driven tool designed to predict Drug-Induced Liver Injury (DILI), has been accepted into the U.S. Food and Drug Administration's (FDA) Drug Development Tool Q